Kyverna Therapeutics Financial Statements 2022-2024 | KYTX

Fifteen years of historical annual and quarterly income statements for Kyverna Therapeutics (KYTX).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM20232022
$0.00$0$7.03
$0.00$0$0
$0.00$0$7.03
$60.20$49.92$28.40
$15.89$12.48$8.01
$0.00$0$0
$0.00$0$0
$-76.10$-62.41$-29.38
$7.51$2.04$0.49
$-68.59$-60.37$-28.89
$0.00$0$0
$-68.59$-60.37$-28.89
$0.00$0$0
$-68.59$-60.37$-28.89
$0.00$0$0
$-68.59$-60.37$-28.89
$-74.67$-60.70$-28.33
$-76.10$-62.41$-29.38
$-22.65$-89.61$-63.43
$-22.65$-89.61$-63.43

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-31
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$27.32$22.48$0$10.41$8.71$0
$6.11$6.88$0$2.90$2.73$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$-33.44$-29.36$0$-13.30$-11.45$0
$4.63$2.67$0$0.21$0.30$0
$-28.80$-26.69$0$-13.09$-11.14$0
$0$0$0$0$0$0
$-28.80$-26.69$0$-13.09$-11.14$0
$0$0$0$0$0$0
$-28.80$-26.69$0$-13.09$-11.14$0
$0$0$0$0$0$0
$-28.80$-26.69$0$-13.09$-11.14$0
$-32.91$-28.88$0$-12.89$-11.05$0
$-33.44$-29.36$0$-13.30$-11.45$0
$-0.67$-1.12$0$-20.86$-12.10$0
$-0.67$-1.12$0.00$-20.86$-12.10$0.00